HOXA9 and leukemia: Overall, the MSI2-HOXA9 leukemia model we developed will contribute to a deeper understanding of how a benign, chronic disease transitions to an aggressive, highly lethal disease and may reveal new vulnerabilities that can be targeted to stop this deadly progression.